Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of AstraZeneca's MEDI-7352?
MEDI-7352 is a monoclonal antibody commercialized by AstraZeneca, with a leading Phase II program in Osteoarthritis Pain. According to Globaldata,...
Data Insights
Risk adjusted net present value: What is the current valuation of AstraZeneca's MEDI-7352?
MEDI-7352 is a monoclonal antibody commercialized by AstraZeneca, with a leading Phase II program in Diabetic Neuropathic Pain. According to...